{"url_path":"/sec/nrg/8-k/2026-01-07/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-01-07","source_url":"https://www.sec.gov/Archives/edgar/data/1013871/0001104659-26-001602-index.html","accession_number":"0001104659-26-001602","cik":"0001013871","ticker":"NRG","issuer_name":"NRG ENERGY, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1013871/0001104659-26-001602-index.html","primary_entity_key":"0001013871","primary_entity_name":"NRG ENERGY, INC."},"word_count":386,"has_tables":true,"body_markdown":"**Item 5.02 Departure of Directors or Certain Officers; Election of\nDirectors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers**\n\n \n\nOn January 6, 2026, the board of directors (the “Board”)\nof NRG Energy, Inc. (the “Company”) appointed Robert Gaudette, the Company’s current Executive Vice President, NRG Business\nand Wholesale Operations, as President of the Company, effective immediately, and as Chief Executive Officer, effective April 30, 2026,\nthe date of the Company’s next annual meeting of stockholders (the “Annual Meeting”). Mr. Gaudette will also be named\nas a director nominee seeking election at the Annual Meeting.\n\n \n\nConcurrently therewith, Lawrence Coben informed\nthe Board of his intention to step down from the Company on April 30, 2026. Dr. Coben will resign as the Company’s President, effective\nimmediately, and will remain as Chief Executive Officer and Chair of the Board through April 30, 2026. Dr. Coben will serve as an advisor\nto the Company from April 30, 2026 through the end of the 2026 fiscal year in order to facilitate an orderly transition. Dr. Coben’s\ndeparture is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies, or\npractices. In connection with Dr. Coben’s departure from the Board on April 30, 2026, the Board has appointed Antonio Carrillo,\nwho has served on the Board since 2019, to succeed Dr. Coben as Chair of the Board.\n\n  \n\nBiographical and other information about Mr. Gaudette\nis included the Company’s definitive proxy statement on Schedule 14A filed with the SEC on March 19, 2025.\nMr. Gaudette does not have any family relationships with any director or executive officer of the Company, and there are no arrangements\nor understandings with any persons pursuant to which Mr. Gaudette has been appointed to his position. In addition, there have been no\ntransactions directly or indirectly involving Mr. Gaudette that would be required to be disclosed pursuant to Item 404(a) of Regulation\nS-K promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).\n\n \n\nAs of the filing of this report, the Compensation\nCommittee of the Board and the Board have not finalized the compensation of Mr. Gaudette in connection with his appointment as Chief Executive\nOfficer and President. The Company will provide this information by filing an amendment to this Report after the information becomes available."}